P643 Development of quantitative ultrasonographic activity score in ileal Crohn’s disease
ECCO'20 Vienna
2020
P644 Post-operative Crohn’s disease recurrence in Glasgow: How common is it and does deprivation matter?
ECCO'20 Vienna
2020
P645 Adalimumab drug monitoring is superior to empirical treatment adjustment in inflammatory bowel disease
ECCO'20 Vienna
2020
P646 Utilisation of indocyanine green fluorescence imaging for Crohn’s disease following intestinal resection
ECCO'20 Vienna
2020
P647 Post-marketing evaluation of reported adverse events of a multi-strain probiotic product confirms that change in manufacturing site had no impact on safety profile
ECCO'20 Vienna
2020
P648 Efficacy including rapid response and safety of tofacitinib in Japanese patients with ulcerative colitis: A preliminary investigation in a specialised IBD centre
ECCO'20 Vienna
2020
P649 Dietary habits in patients with inactive Crohn’s disease: Results of a controlled study
ECCO'20 Vienna
2020
P650 Outcomes of endoscopic balloon dilation for luminal strictures in Crohn’s disease
ECCO'20 Vienna
2020
P652 Underweight patients with Crohn’s disease and without vitamin D supplementation are at high risk of vitamin D deficiency
ECCO'20 Vienna
2020
P654 Influence of the interval of time between anti-TNF and vedolizumab or ustekinumab in the response to treatment in patients with inflammatory bowel disease
ECCO'20 Vienna
2020
P655 Pharmacokinetics of ustekinumab in children and adolescents with moderately to severely active Crohn’s disease: Results from UniStar, a phase 1 study
ECCO'20 Vienna
2020
P656 Clinical implications of endoscopic submucosal dissection in management of patients with ulcerative colitis-associated dysplasia
ECCO'20 Vienna
2020
P658 A pooled analysis of serum phosphate measurements and transient decreased phosphate levels in 45 interventional trials with ferric carboxymaltose
ECCO'20 Vienna
2020
P659 The impact of total colectomy on the course of extraintestinal manifestations in Swiss IBD cohort study patients
ECCO'20 Vienna
2020
P660 Evaluating the effectiveness of disease assessment at 2 weeks following a course of oral steroids: Does early intervention affect outcomes?
ECCO'20 Vienna
2020